检索结果 - Jibing Chen
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Li... 由 Yu-Mei Yang, Zilin Qin, Duanming Du, Yumin Wu, Shuibo Qiu, Feng Mu, Kengcheng Xu, Jibing Chen
出版 2018Artigo -
11
-
12
-
13
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma 由 Mohammed Alnaggar, Yan Xu, Jingxia Li, Junyi He, Jibing Chen, Man Li, Qingling Wu, Lin Li, Yingqing Liang, Xiaohua Wang, Jiawei Li, Yi Hu, Yan Chen, Kecheng Xu, Yangzhe Wu, Zhinan Yin
出版 2019Artigo -
14
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer 由 Yan Xu, Zheng Xiang, Mohammed Alnaggar, Léonce Kouakanou, Jiawei Li, Junyi He, Jiashuang Yang, Yi Hu, Yan Chen, Lin Li, Jianlei Hao, Jingxia Li, Jibing Chen, Man Li, Qingling Wu, Christian Peters, Qinghua Zhou, Jianshuang Li, Yingqing Liang, Xiaohua Wang, Baohui Han, Meili Ma, Dieter Kabelitz, Kecheng Xu, Wenwei Tu, Yangzhe Wu, Zhinan Yin
出版 2020Artigo
相关主题
Medicine
Internal medicine
Cancer
Oncology
Immunology
Immunotherapy
Biology
Cancer research
Immune system
Biochemistry
Gastroenterology
Gene
Genetics
Lung cancer
Adverse effect
Cancer immunotherapy
Electroporation
Hepatocellular carcinoma
Irreversible electroporation
Cell
Cell biology
Cell therapy
Chemistry
Clinical trial
Endocrinology
Intensive care medicine
Paleontology
Pancreatic cancer
Signal transduction
Stage (stratigraphy)